Now, he has been focused on a new treatment method that calls on people to inhale leukine, which is a naturally occurring molecule that can defend the lungs.
“Because it is given as an inhaled mist, it targets the lung to alleviate respiratory failure and reduce the need for oxygen therapy. This is a key step in preventing the need for ICU care and support on a mechanical ventilator.”
One clinical trial in Belgium looked at the drug and found that it generated T-cells. According to Paine, this can create an immune response that could tackle COVID-19 variants, he said.
He told me “because leukine works through the body’s natural defense mechanisms it will be beneficial even if variants of the virus arise for which vaccines are less effective.”
That treatment method might come in handy these days, as experts continue to warn about variants that might evade vaccines. For example, recent research suggested the lambda variant might evade COVID-19 vaccines.
“If another one comes along that has an equally high capability of transmitting but also is much more severe, then we could really be in trouble,” he said, according to The Sacramento Bee. “People who are not getting vaccinated mistakenly think it’s only about them. But it isn’t. It’s about everybody else, also.”
Indeed, other experts told Newsweek that the delta variant won’t be the last coronavirus variant to spread wildly. More mutations, experts said, will come and could potentially spread rapidly.
“I wouldn’t be incredibly surprised if something else came along that’s even more transmissible,” Eric Vail, director of molecular pathology at Cedars-Sinai Medical Center, told Newsweek